Dr. Christopher Gerard Bunick, MD, PhD

Dr. Bunick practices at Yale Medicine in New Haven, Connecticut.

Dr. Bunick's NPI, 1457527442, was assigned on April 30, 2008. Dr. Bunick graduated from Vanderbilt University School Of Medicine in 2008. Dr. Bunick holds Connecticut license 50906.

Dr. Bunick's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Bunick's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Bunick is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Bunick to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bunick practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bunick's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bunick is licensed in Connecticut.

CMS data shows 1,865 Medicare services from Dr. Bunick across 16 procedure codes in 2024, for 595 Medicare patients. Medicare paid $95,541 for them. Every service was in an office.

CMS counts 595 Medicare patients who saw Dr. Bunick in 2024. The largest group is 65 to 74, with 255 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bunick's median patient age at 67, with 48% women.

In 2024, Dr. Bunick wrote 1,606 Medicare Part D claims for 504 patients. 73% of them were for generic drugs. CMS names the drug for 1,384 of them, across 32 drugs with 11 or more claims each, at $2,140,964 in total drug cost. In 2023, CMS named 1,400 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Bunick for performance year 2024, reported as part of a group. Dr. Bunick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 417 procedures of removal of skin lesions by Dr. Bunick, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Bunick in 2018. Dr. Bunick has published most often in Br J Dermatol. Dr. Bunick's most frequent co-authors are Keith A. Choate, MD, PhD, Adam Edward Bennett, MD and Earl J. Glusac, MD.

Dmand AI links Dr. Bunick to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. Bunick that name 1 trial.

CMS Open Payments shows 829 general payments to Dr. Bunick from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. LEO Pharma Inc. paid the most, $152,600. It also lists 8 research payments totaling $6,250 from 2023 to 2025, naming 1 clinical trial.

Dr. Bunick graduated from Vanderbilt University School Of Medicine in 2008.